Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You or your child must be under the care of a children's blood and cancer specialist (pediatric hematology/oncology doctor).
- You or your child must be currently receiving a specific cancer medication called recombinant Erwinia asparaginase as part of their cancer treatment.
Who may not be able to join:
- Children who are under 1 year of age cannot take part.
- Patients who have already received recombinant Erwinia asparaginase within the last two weeks are not eligible.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Catherine E. Martin, PharmD, RPh, Mayo Clinic in Rochester
Phone: 855-776-0015
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of patients who develop hyperammonemia
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.